Compare PRME & HIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PRME | HIVE |
|---|---|---|
| Founded | 2019 | 1987 |
| Country | United States | United States |
| Employees | N/A | 20 |
| Industry | Medicinal Chemicals and Botanical Products | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 601.1M | 728.2M |
| IPO Year | 2022 | N/A |
| Metric | PRME | HIVE |
|---|---|---|
| Price | $4.11 | $3.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 6 |
| Target Price | ★ $9.31 | $8.33 |
| AVG Volume (30 Days) | 3.8M | ★ 17.0M |
| Earning Date | 11-07-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.20 |
| Revenue | $5,977,000.00 | ★ $193,254,000.00 |
| Revenue This Year | $111.80 | $185.64 |
| Revenue Next Year | N/A | $44.55 |
| P/E Ratio | ★ N/A | $21.16 |
| Revenue Growth | ★ 647.13 | 57.09 |
| 52 Week Low | $1.11 | $1.26 |
| 52 Week High | $6.94 | $7.84 |
| Indicator | PRME | HIVE |
|---|---|---|
| Relative Strength Index (RSI) | 52.01 | 36.82 |
| Support Level | $3.95 | $2.99 |
| Resistance Level | $4.42 | $3.31 |
| Average True Range (ATR) | 0.30 | 0.25 |
| MACD | 0.12 | 0.06 |
| Stochastic Oscillator | 76.72 | 23.51 |
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
HIVE Digital Technologies Ltd is in the business of providing infrastructure solutions in the blockchain industry. It focuses on the mining and sale of digital currencies. Its geographical segments include Canada, Sweden, Iceland, Switzerland, and Bermuda, out of which the majority of the revenue comes from Bermuda.